Bill Shannon

601 total citations
23 papers, 443 citations indexed

About

Bill Shannon is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Bill Shannon has authored 23 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Bill Shannon's work include Clostridium difficile and Clostridium perfringens research (9 papers), Gut microbiota and health (8 papers) and Pharmaceutical Economics and Policy (5 papers). Bill Shannon is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (9 papers), Gut microbiota and health (8 papers) and Pharmaceutical Economics and Policy (5 papers). Bill Shannon collaborates with scholars based in Ireland, United States and Canada. Bill Shannon's co-authors include Suzanne S. Dunne, Colum Dunne, Walter Cullen, Ailish Hannigan, Niamh M. Cummins, Ken Blount, Lisungu Chieza, Pawel Gajer, Jacques Ravel and Rupert Kaul and has published in prestigious journals such as Gastroenterology, The Journal of Infectious Diseases and The American Journal of Gastroenterology.

In The Last Decade

Bill Shannon

22 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bill Shannon Ireland	9	206	117	77	72	63	23	443
Priya Bahri Netherlands	14	120 0.6×	58 0.5×	46 0.6×	58 0.8×	76 1.2×	30	437
Unni Gopinathan Norway	13	130 0.6×	92 0.8×	76 1.0×	12 0.2×	58 0.9×	47	475
Tido von Schoen-Angerer Switzerland	12	182 0.9×	71 0.6×	95 1.2×	32 0.4×	100 1.6×	40	568
Austin Johnson United States	11	120 0.6×	30 0.3×	266 3.5×	20 0.3×	66 1.0×	57	556
Alex Dodoo Ghana	10	84 0.4×	65 0.6×	138 1.8×	17 0.2×	52 0.8×	14	406
H. Denman Scott United States	10	76 0.4×	35 0.3×	45 0.6×	38 0.5×	107 1.7×	22	645
Kenneth Hartigan‐Go Philippines	12	46 0.2×	34 0.3×	65 0.8×	38 0.5×	82 1.3×	35	526
Germán Velásquez Switzerland	9	160 0.8×	77 0.7×	65 0.8×	22 0.3×	18 0.3×	25	378
Kim Ward South Africa	10	180 0.9×	77 0.7×	87 1.1×	12 0.2×	21 0.3×	17	333
Amanda Harrington United States	13	117 0.6×	24 0.2×	37 0.5×	18 0.3×	91 1.4×	24	596

Countries citing papers authored by Bill Shannon

Since Specialization

Citations

This map shows the geographic impact of Bill Shannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill Shannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill Shannon more than expected).

Fields of papers citing papers by Bill Shannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill Shannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill Shannon. The network helps show where Bill Shannon may publish in the future.

Co-authorship network of co-authors of Bill Shannon

This figure shows the co-authorship network connecting the top 25 collaborators of Bill Shannon. A scholar is included among the top collaborators of Bill Shannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill Shannon. Bill Shannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blount, Ken, Heidi H. Hau, Romeo Papazyan, et al.. (2022). Su1596: MICROBIOME AND BILE ACID RESTORATION WAS CONSISTENT ACROSS THREE CLINICAL TRIALS OF RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A COMBINED ANALYSIS. Gastroenterology. 162(7). S–645. 4 indexed citations

Blount, Ken, et al.. (2021). 1064. Treatment Success in Reducing Recurrent Clostridioides difficile Infection with Investigational Live Biotherapeutic RBX2660 Is Associated with Microbiota Restoration: Consistent Evidence from a Phase 3 Clinical Trial. Open Forum Infectious Diseases. 8(Supplement_1). S624–S625. 8 indexed citations

Papazyan, Romeo, Bryan C. Fuchs, Ken Blount, Carlos G. Gonzalez, & Bill Shannon. (2021). 1039. Rapid Restoration of Bile Acid Compositions After Treatment with RBX2660 for Recurrent Clostridioides difficile Infection—Results from the PUNCH CD3 Phase 3 Trial. Open Forum Infectious Diseases. 8(Supplement_1). S610–S610. 6 indexed citations

Khanna, Sahil, Darrell S. Pardi, Dale N. Gerding, et al.. (2019). Tu1880 – Durable Freedom from Clostridium Difficile Infection Recurrence and Microbiome Restoration During Six-Month Follow-Up For a Phase 1 Clinical Trial of Rbx7455?An Investigational Room Temperature-Stable, Oral Microbiotabased Therapeutic. Gastroenterology. 156(6). S–1158. 2 indexed citations

Blount, Ken, Courtney Jones, Elena Deych, & Bill Shannon. (2018). 1966. Evaluating a Prototype Microbiome Health Index (MHI) as a Measure of Microbiome Restoration Using Data Derived From a Published Study of Fecal Microbiota Transplant (FMT) to Treat Recurrent Clostridium difficile Infections (rCDI). Open Forum Infectious Diseases. 5(suppl_1). S570–S570. 3 indexed citations

Khanna, Sahil, Darrell S. Pardi, Dale N. Gerding, et al.. (2018). RBX7455 - a Non-Frozen, Lyophilized, Oral Microbiota Reduces Clostridium difficileInfection Recurrence and Restores Patients‘ Microbiomes Presidential Poster Award. The American Journal of Gastroenterology. 113(Supplement). S107–S107. 1 indexed citations

Shannon, Bill, Pawel Gajer, Tae Joon Yi, et al.. (2017). Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology. The Journal of Infectious Diseases. 215(9). 1366–1375. 73 indexed citations

Dubberke, Erik R., Robert Orenstein, Christine Lee, et al.. (2017). Microbiome Profile is Distinct in Patients with Successful Response to Microbiota-Based Drug RBX2660 Relative to Placebo Responders. Open Forum Infectious Diseases. 4(suppl_1). S538–S538. 2 indexed citations

Ray, Arnab, et al.. (2016). Does the Donor Matter? Results from PUNCH CD 2: A Randomized Controlled Trial of a Microbiota-based Drug for Recurrent Clostridium difficile Infection. The American Journal of Gastroenterology. 111. S65–S66. 1 indexed citations

10.

Dunne, Suzanne S., Bill Shannon, Ailish Hannigan, Colum Dunne, & Walter Cullen. (2014). Physician and pharmacist perceptions of generic medicines: What they think and how they differ. Health Policy. 116(2-3). 214–223. 31 indexed citations

11.

Dunne, Suzanne S., Bill Shannon, Walter Cullen, & Colum Dunne. (2014). Perceptions and Attitudes of Community Pharmacists Towards Generic Medicines. Journal of Managed Care Pharmacy. 20(11). 1138–1146. 13 indexed citations

12.

Dunne, Suzanne S., Bill Shannon, Walter Cullen, & Colum Dunne. (2014). Beliefs, perceptions and behaviours of GPs towards generic medicines. Family Practice. 31(4). 467–474. 22 indexed citations

13.

Dunne, Suzanne S., Bill Shannon, Colum Dunne, & Walter Cullen. (2014). Patient Perceptions of Generic Medicines: A Mixed-Methods Study. Patient. 7(2). 177–185. 38 indexed citations

14.

Dunne, Suzanne S., Bill Shannon, Colum Dunne, & Walter Cullen. (2013). A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology. 14(1). 1–1. 158 indexed citations

15.

Dunne, Suzanne S., Niamh M. Cummins, Ailish Hannigan, et al.. (2013). Generic medicines: an evaluation of the accuracy and accessibility of information available on the internet. BMC Medical Informatics and Decision Making. 13(1). 115–115. 11 indexed citations

16.

Dunne, Suzanne S., Niamh M. Cummins, Ailish Hannigan, et al.. (2013). A Method for the Design and Development of Medical or Health Care Information Websites to Optimize Search Engine Results Page Rankings on Google. Journal of Medical Internet Research. 15(8). e183–e183. 37 indexed citations

17.

O’Riordan, Margaret, et al.. (2013). Submission from the Irish College of General Practitioners to the Oireachtas Joint Committee on Health and Children on the General Scheme of the Protection of Life during Pregnancy Bill 2013. Lenus, The Irish Health Repository (Dr Steevens Hospital Library). 2 indexed citations

18.

Shannon, Bill. (1994). Nutrition Labelling. British Food Journal. 96(4). 40–44. 25 indexed citations

19.

Shannon, Bill. (1993). An Operational Perspective on the Handling and Disposal of NORM in the Gulf of Mexico. 1 indexed citations

20.

Shannon, Bill. (1992). Healthy Eating: A Retail Perspective. British Food Journal. 94(3). 26–28.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact